Tuesday, August 11, 2026

How Celltrion’s Omlyclo is Dominating Spain’s Omalizumab Market: A First-Mover Success Story

Celltrion's Omlyclo treatment is thriving in Spain, capturing over 60% of the omalizumab market with innovative strategies and strong demand.

Mediwhale’s DrNoon Receives CE MDR Certification in Europe for Cardiovascular Risk Prediction

Mediwheel's retinal AI solution 'DrNoon' has received CE MDR certification, enhancing its credibility in the European medical device market.

China’s Swimming Superstar Sun Yang Makes Comeback After Controversial Ban

Sun Yang is set to make his comeback in the China National Summer Swimming Championships, competing in Hefei, Anhui.

Tag: delisting

Drug Development Is Inherently Unprofitable, Biotech Industry Warns as Delisting Reform Looms

South Korea's biotech sector faces stricter delisting rules, raising concerns over innovation and funding for drug development.

Top News

- Our Sponsors Ad -

Follow us